Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing Type
144
Filing Date
5/29/2025
Updated
5/30/25, 2:18 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities